申请人:Eisai Co., Ltd.
公开号:US04402966A1
公开(公告)日:1983-09-06
An imidazole compound of the formula: ##STR1## wherein R.sub.1 is lower alkyl, R.sub.2 is hydrogen or lower alkyl, and R.sub.3, R.sub.4 and R.sub.5 are hydrogen, lower alkyl, trifluoromethyl, amino, mono- or di-lower alkylamino, heterocyclic amino, halogen or ##STR2## (in which R.sub.6 is hydrogen, lower alkyl or lower alkylsulfonyl, A is carbonyl or sulfonyl, and R.sub.7 is lower alkyl, halogenated lower alkyl, mono- or di-lower alkylamino, mono- or di-lower alkylaminoalkyl, unsubstituted phenyl or phenyl having halogen, lower alkyl, lower alkoxy or trifluoromethyl, phenylamino or phenylamino having halogen, lower alkyl, lower alkoxy or trifluoromethyl); and their pharmaceutically acceptable acid addition salts. The compounds are useful for treating patients suffering from depression.
一种咪唑化合物的公式:##STR1## 其中R.sub.1是较低的烷基,R.sub.2是氢或较低的烷基,而R.sub.3,R.sub.4和R.sub.5是氢,较低的烷基,三氟甲基,氨基,单-或双-较低的烷基氨基,杂环氨基,卤素或##STR2##(其中R.sub.6是氢,较低的烷基或较低的烷基磺酰基,A是羰基或磺酰基,而R.sub.7是较低的烷基,卤素化的较低的烷基,单-或双-较低的烷基氨基,单-或双-较低的烷基氨基烷基,未取代的苯基或苯基,其中卤素,较低的烷氧基或三氟甲基,苯基氨基或苯基氨基,其中卤素,较低的烷氧基或三氟甲基);以及它们的药学上可接受的酸盐。该化合物可用于治疗患有抑郁症的患者。